Prostate Cancer Screening Men will undergo a digital rectal exam and PSA annually beginning at age 50. Cervical, Uterine and Ovarian Cancer An initial biannual exam and pap smear are recommended for all patients who are sexually active or >or= 18 years of age. Additional testing or consultations as directed by the consulting hepatologist. a. After core testing is completed, the case is presented at the Liver Transplant Selection patient’s Committee meeting held weekly. b. The committee decision will be one of four possible outcomes: i. Approved pending financial clearance – Once financial approval has been received, the patient will be placed on waiting list. ii. Denied Patient is referred back to referring MD for alternative treatment options or provided with other Centers. iii. Early Patient is referred back to referring MD for care & will reevaluate in 6 months. Will reevaluate sooner if patient condition deteriorates. iv. Further work-up needed. Additional consults/testing or treatment needed. The transplant center will schedule any tests &/or consults. Patients requiring weight loss, A & D treatment or substance abuse rehabilitation will not be followed until all requirements are met. c. Patient will be scheduled for with hepatologist after presentation at selection “wrap-up session” conference for discussion of committee decision and test review with the patient. d. Patients and referring are notified of the committee decision by phone and letter. MD’s Approved by: Liver Transplant Leadership Group _____________________________________ Stuart Knechtle, M.D. Chair, Liver Transplant Leadership Group Director, Liver Transplant Program Hepatologist Approval:
Prostate Cancer Screening Men will undergo a digital rectal exam and PSA annually beginning at age 50. Cervical, Uterine and Ovarian Cancer An initial biannual exam and pap smear are recommended for all patients who are sexually active or >or= 18 years of age. Additional testing or consultations as directed by the consulting hepatologist. a. After core testing is completed, the patient’s case is presented at the Liver Transplant Selection Committee meeting held weekly. b. The committee decision will be one of four possible outcomes: i. Approved – pending financial clearance Once financial approval has been received, the patient will be placed on waiting list. ii. Denied Patient is referred back to referring MD for alternative treatment options or provided with other Centers. iii. Early Patient is referred back to referring MD for care & will reevaluate in 6 months. Will reevaluate sooner if patient condition deteriorates. iv. Further work-up needed. Additional consults/testing or treatment needed. The transplant center will schedule any tests &/or consults. Patients requiring weight loss, A & D treatment or substance abuse rehabilitation will not be followed until all requirements are met. c. Patient will be scheduled for “wrap-up session” with hepatologist after presentation at selection conference for discussion of committee decision and test review with the patient. d. Patients and referring MD’s are notified of the committee decision by phone and letter. Approved by: Liver Transplant Leadership Group _____________________________________ Stuart Knechtle, M.D. Chair, Liver Transplant Leadership Group Director, Liver Transplant Program Hepatologist Approval: